General Information of the Compound
| Compound ID |
CP0775034
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5Z)-5-((7-bromo-1H-indol-3-yl)methylene)-2-(methylimino)imidazolidin-4-one
Show/Hide
|
||||||||||||||||||
| Formula |
C13H11BrN4O
|
||||||||||||||||||
| Molecular Weight |
319.162
|
||||||||||||||||||
| Canonical SMILES |
C/N=C1\NC(=O)/C(=C/c2c[nH]c3c(Br)cccc23)N1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C13H11BrN4O/c1-15-13-17-10(12(19)18-13)5-7-6-16-11-8(7)3-2-4-9(11)14/h2-6,16H,1H3,(H2,15,17,18,19)/b10-5-
Show/Hide
|
||||||||||||||||||
| InChIKey |
SPRYLBSGZYATLJ-YHYXMXQVSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01492, 5-hydroxytryptamine receptor 2A
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Protein ID: PT01513, 5-hydroxytryptamine receptor 5A